Atlas Trials

Rituximab in Eosinophilic Granulomatosis With Polyangiitis

Clinical trial NCT02807103 · COMPLETED

Trial details

NCT number
NCT02807103
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Start date
2016-12-05
Primary completion
2020-10-21
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.